The Positive Association between Subclinical Hypothyroidism and Newly-Diagnosed Hypertension Is More Explicit in Female Individuals Younger than 65

• Published in: Endocrinology and metabolism (Seoul) Vol. 36; no. 4; pp. 778 - 789
• Main Authors: Wang, Xichang, Wang, Haoyu, Yan, Li, Yang, Lihui, Xue, Yuanming, Yang, Jing, Yao, Yongli, Tang, Xulei, Tong, Nanwei, Wang, Guixia, Zhang, Jinan, Wang, Youmin, Ba, Jianming, Chen, Bing, Du, Jianling, He, Lanjie, Lai, Xiaoyang, Li, Yanbo, Yan, Zhaoli, Liao, Eryuan, Liu, Chao, Liu, Libin, Qin, Guijun, Qin, Yingfen, Quan, Huibiao, Shi, Bingyin, Sun, Hui, Ye, Zhen, Zhang, Qiao, Zhang, Lihui, Zhu, Jun, Zhu, Mei, Li, Yongze, Teng, Weiping, Shan, Zhongyan
• Format: Journal Article
• Language: English
• Published: Korea (South) Korean Endocrine Society 01.08.2021; 대한내분비학회
• Subjects: Adolescent; Adult; Aged; Blood Pressure; Female; Humans; hypertension; Hypertension - epidemiology; hypothyroidism; Hypothyroidism - diagnosis; Hypothyroidism - epidemiology; Male; Original; Reference Values; Thyrotropin; United States; 내과학; United States; Hypertension; Hypothyroidism; Blood pressure
• ISSN: 2093-596X; 2093-5978
• DOI: 10.3803/ENM.2021.1101

Subclinical hypothyroidism (SCH) is the most common thyroid dysfunction, and its relationship with blood pressure (BP) has been controversial. The aim of the study was to analyze the association between SCH and newly-diagnosed hypertension. Based on data from the Thyroid disease, Iodine nutrition and Diabetes Epidemiology (TIDE) study, 49,433 euthyroid individuals and 7,719 SCH patients aged ≥18 years were enrolled. Patients with a history of hypertension or thyroid disease were excluded. SCH was determined by manufacturer reference range. Overall hypertension and stage 1 and 2 hypertension were diagnosed according to the guidelines issued by the American College of Cardiology/American Heart Association in 2017. The prevalence of overall hypertension (48.7%), including stage 1 (28.9%) and 2 (19.8%) hypertension, increased significantly in SCH patients compared with euthyroid subjects. With elevated serum thyroid stimulating hormone (TSH) level, the hypertension prevalence also increased significantly from the euthyroid to different SCH subgroups, which was more profound in females or subjects aged <65 years. The age- and sex-specific regression analysis further demonstrated the same trends in the general population and in the 1:1 propensity matched population. Similarly, several BP components (i.e., systolic, diastolic, and mean arterial BP) were positively associated with TSH elevation, and regression analysis also confirmed that all BP components were closely related with SCH in female subjects aged <65 years. The prevalence of hypertension increases for patients with SCH. SCH tends to be associated with hypertension and BP components in females younger than 65 years.